Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lygature is a Netherlands-based not-for-profit organization that drives medical innovations by managing public-private partnerships in life sciences. It was formed in 2015 from the merger of CTMM and TI Pharma. The organization specializes in facilitating complex collaborations between industry, academia, government agencies, NGOs and other stakeholders to accelerate the development of new medical solutions addressing unmet needs worldwide. Its activities span partnership management for over 20 major projects with more than 100 partners globally. Key initiatives include regulatory science platforms like Escher and large-scale research consortia targeting diverse therapeutic areas including oncology and infectious diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lygature.